Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
6.67M
-
Shares change
-
-48.7K
-
Total reported value, excl. options
-
$30M
-
Value change
-
-$216K
-
Number of buys
-
10
-
Number of sells
-
-20
-
Price
-
$4.50
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q2 2014
48 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q2 2014.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.67M shares
of 15M outstanding shares and own 44.57% of the company stock.
Largest 10 shareholders include ARIEL INVESTMENTS, LLC (2.66M shares), DIMENSIONAL FUND ADVISORS LP (857K shares), BlackRock Institutional Trust Company, N.A. (508K shares), MILLENNIUM MANAGEMENT LLC (505K shares), NEW YORK STATE COMMON RETIREMENT FUND (306K shares), VANGUARD GROUP INC (272K shares), GW HENSSLER & ASSOCIATES LTD (216K shares), UNITED CAPITAL FINANCIAL ADVISERS, LLC (198K shares), KESTREL INVESTMENT MANAGEMENT CORP (138K shares), and LSV ASSET MANAGEMENT (100K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.